HDAC inhibitor PCI-34051, Purity ≥98%

Cat. No.: X23-10-ZQ311

HDAC inhibitor PCI-34051, Purity ≥98%

Synonym: 950762-95-5; PCI-34051; N-Hydroxy-1-(4-methoxybenzyl)-1H-indole-6-carboxamide; PCI 34051; N-Hydroxy-1-[(4-methoxyphenyl)methyl]indole-6-carboxamide; PCI34051; HDAC inhibitor

  • MDL: MFCD11114393
  • CAS Number: 950762-95-5
  • Compound CID: 24753719
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
PCI-34051, soluble in DMSO and insoluble in ethanol and water, induces DNA damage and the inhibition of DNA repair processes. It targets HDAC1, HDAC6, HDAC10, HDAC2, HDAC3, and HDAC8.
Molecular Weight
296.3
Molecular Formula
C17H16N2O3
Targets
HDAC1: 4 μM; HDAC6: 2.9 μM; HDAC10: 13 μM; HDAC2: >50 μM; HDAC3: >50 μM; HDAC8: 10 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 58 mg/mL (195.73 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
PCI-34051 is utilized in studies for its selective inhibition of HDAC8, thus aiding in cancer research and epigenetic studies.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.